130 related articles for article (PubMed ID: 25956408)
1. Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion.
Winkler CW; Race B; Phillips K; Peterson KE
Acta Neuropathol; 2015 Aug; 130(2):233-45. PubMed ID: 25956408
[TBL] [Abstract][Full Text] [Related]
2. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
[TBL] [Abstract][Full Text] [Related]
3. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.
Winkler CW; Myers LM; Woods TA; Carmody AB; Taylor KG; Peterson KE
J Neuroinflammation; 2017 Mar; 14(1):62. PubMed ID: 28340587
[TBL] [Abstract][Full Text] [Related]
5. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
6. Identification of age-specific gene regulators of La Crosse virus neuroinvasion and pathogenesis.
Basu R; Ganesan S; Winkler CW; Anzick SL; Martens C; Peterson KE; Fraser IDC
Nat Commun; 2023 May; 14(1):2836. PubMed ID: 37202395
[TBL] [Abstract][Full Text] [Related]
7. The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.
Durrant DM; Ghosh S; Klein RS
ACS Chem Neurosci; 2016 Apr; 7(4):464-9. PubMed ID: 27058872
[TBL] [Abstract][Full Text] [Related]
8. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
Virol J; 2007 May; 4():41. PubMed ID: 17488515
[TBL] [Abstract][Full Text] [Related]
9. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Blakqori G; Delhaye S; Habjan M; Blair CD; Sánchez-Vargas I; Olson KE; Attarzadeh-Yazdi G; Fragkoudis R; Kohl A; Kalinke U; Weiss S; Michiels T; Staeheli P; Weber F
J Virol; 2007 May; 81(10):4991-9. PubMed ID: 17344298
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
Charles PC; Walters E; Margolis F; Johnston RE
Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437
[TBL] [Abstract][Full Text] [Related]
11. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy.
Monath TP; Cropp CB; Harrison AK
Lab Invest; 1983 Apr; 48(4):399-410. PubMed ID: 6300550
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
13. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
14. La Crosse viremias in Mongolian gerbils (Meriones unguiculatis).
Osorio JE; Yuill TM
Am J Trop Med Hyg; 1996 Nov; 55(5):567-9. PubMed ID: 8940992
[TBL] [Abstract][Full Text] [Related]
15. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis.
Detje CN; Lienenklaus S; Chhatbar C; Spanier J; Prajeeth CK; Soldner C; Tovey MG; Schlüter D; Weiss S; Stangel M; Kalinke U
J Virol; 2015 Mar; 89(5):2731-8. PubMed ID: 25540366
[TBL] [Abstract][Full Text] [Related]
16. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes.
Hollidge BS; Nedelsky NB; Salzano MV; Fraser JW; González-Scarano F; Soldan SS
J Virol; 2012 Aug; 86(15):7988-8001. PubMed ID: 22623766
[TBL] [Abstract][Full Text] [Related]
17. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
Schuh T; Schultz J; Moelling K; Pavlovic J
Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
[TBL] [Abstract][Full Text] [Related]
18. Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.
Cain MD; Salimi H; Gong Y; Yang L; Hamilton SL; Heffernan JR; Hou J; Miller MJ; Klein RS
J Neuroimmunol; 2017 Jul; 308():118-130. PubMed ID: 28501330
[TBL] [Abstract][Full Text] [Related]
19. La Crosse virus neuroinvasive disease - Missouri, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(28):869-71. PubMed ID: 20651642
[TBL] [Abstract][Full Text] [Related]
20. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA.
Lambert AJ; Fryxell RT; Freyman K; Ulloa A; Velez JO; Paulsen D; Lanciotti RS; Moncayo A
Emerg Infect Dis; 2015 May; 21(5):833-6. PubMed ID: 25898269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
